Table of Content

The Comprehensive List Of 330 Companies Is Mentioned in the Sample Document


1. Beijing Kawin Technology Share-Holding

1.1 Business Overview

1.2 Clinical Pipeline Insight
1.2.1 Marketed


2. Beijing SyngenTech Co.

2.1 Business Overview

2.2 Clinical Pipeline Insight
2.2.1 Research
2.2.2 Preclinical
2.2.3 Phase-I


3. China Oncology Focus

3.1 Businesss Overview

3.2 Clinical Pipeline Insight
3.2.1 Preclinical
3.2.2 Phase-I
3.2.3 Phase-III
3.2.4 Preregistration


4. Coherent Biopharma

4.1 Business Overview

4.2 Clinical Pipeline Insight
4.2.1 Preclinical
4.2.2 Phase-I
4.2.3 Phase-I/II


5. Hepagene Therapeutics

5.1 Business Overview

5.2 Clinical Pipeline Insight
5.2.1 Preclinical
5.2.2 Phase-II


6. Lynk Pharmaceuticals

6.1 Business Overview

6.2 Clinical Pipeline Insight
6.2.1 Research
6.2.2 Preclinical
6.2.3 Phase-I
6.2.4 Phase-II
.
.
.
.

325. Beijing Tiantan Biological Products Company

325.1 Business Overview

325.2 Clinical Pipeline Insight
325.2.1 Phase-III


326. Atom Bioscience

326.1 Business Overview

326.2 Clinical Pipeline Insight
326.2.1 Phase-II


327. Shanghai Jiatan Pharmatech

327.1 Business Overview

327.2 Clinical Pipeline Insight
327.2.1 Phase-III


328. Rongchang Biopharmaceutical (Yantai) Co., Ltd

328.1 Business Overview

328.2 Clinical Pipeline Insight
328.2.1 Phase-III


329. Full-Life Technologies

329.1 Business Overview

329.2 Clinical Pipeline Insight
329.2.1 Preclinical


330. NovoCodex Biopharmaceuticals

330.1 Business Overview